GELS
Gelteq Limited Ordinary Shares
NASDAQ: GELS · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$0.66
+2.00% today
Updated 2026-05-01
Market cap
$6.91M
P/E ratio
—
P/S ratio
16.72x
EPS (TTM)
$-0.52
Dividend yield
—
52W range
$1 – $4
Volume
0.0M
Gelteq Limited Ordinary Shares (GELS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-2,969.00%
ROE
-43.00%
ROA
-15.00%
Debt/equity
0.27x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2020 | — | $-375587.00 | — | — | — |
| 2021 | $0.00 | $-648921.00 | — | — | — |
| 2022 | $147536.00 | $-3.37M | 35.69% | -2,164.39% | -2,283.44% |
| 2023 | $79843.00 | $-3.51M | 38.72% | -3,885.31% | -4,391.39% |
| 2024 | $0.00 | $-3.55M | — | — | — |
| 2025 | $165645.00 | $-6.65M | 100.00% | -3,317.65% | -4,011.86% |